Increased expression of SHP-1 is associated with local recurrence after radiotherapy in patients with nasopharyngeal carcinoma

1. Chang ET, Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 2006; 15: 1765-77.10.1158/1055-9965.EPI-06-035317035381Search in Google Scholar

2. Greene FL, Page DL, Fleming ID, Fritz A. AJCC cancer staging manual. 6th edition. New York, NY: Springer; 2002.10.1007/978-1-4757-3656-4Search in Google Scholar

3. Lee AW, Lin JC, Ng WT. Current management of nasopharyngeal cancer. Semin Radiat Oncol 2012; 22: 233-44.10.1016/j.semradonc.2012.03.00822687948Search in Google Scholar

4. Wee J, Tan EH, Tai BC, Wong HB, Leong SS, Tan T, et al. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/ International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety. J Clin Oncol 2005; 23: 6730-8.10.1200/JCO.2005.16.79016170180Search in Google Scholar

5. Langendijk JA, Leemans CR, Buter J, Berkof J, Slotman BJ. The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature. J Clin Oncol 2004; 22: 4604-12.10.1200/JCO.2004.10.07415542811Search in Google Scholar

6. Kwong DL, Sham JS, Au GK, Chua DT, Kwong PW, Cheng AC, et al. Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study. J Clin Oncol 2004; 22: 2643-53.10.1200/JCO.2004.05.17315226332Search in Google Scholar

7. Lin JC, Jan JS, Hsu CY, Liang WM, Jiang RS, Wang WY. Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival. J Clin Oncol 2003; 21: 631-7.10.1200/JCO.2003.06.15812586799Search in Google Scholar

8. Chua DT, Ma J, Sham JS, Mai HQ, Choy DT, Hong MH, et al. Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials. J Clin Oncol 2005; 23: 1118-24.10.1200/JCO.2005.12.08115657403Search in Google Scholar

9. Čarman J, Strojan P. Nasopharyngeal carcinoma in Slovenia, 1990-2003 (results of treatment with conventional two-dimensional radiotherapy). Rep Pract Oncol Radiother 2012; 17: 71-8.10.1016/j.rpor.2012.01.002386317624377003Search in Google Scholar

10. Harrington K, Jankowska P, Hingorani M. Molecular biology for the radiation oncologist: the 5Rs of radiobiology meet the hallmarks of cancer. Clin Oncol 2007; 19: 561-71.10.1016/j.clon.2007.04.00917591437Search in Google Scholar

11. Pajonk F, Vlashia E, McBridea WH. Radiation resistance of cancer stem cells: The 4 R’s of radiobiology revisited. Stem Cells 2010; 28: 639-48.10.1002/stem.318294023220135685Search in Google Scholar

12. López-Ruiz P, Rodriguez-Ubreva J, Cariaga AE, Cortes MA, Colás B. SHP-1 in cell-cycle regulation. Anticancer Agents Med Chem 2011; 11: 89-98.10.2174/18715201179494115421291405Search in Google Scholar

13. Rodriguez-Ubreva FJ, Cariaga-Martinez AE, Cortes MA, Romero-De Pablos M, Ropero S, López-Ruiz P, et al. Knockdown of protein tyrosine phosphatase SHP-1 inhibits G1/S progression in prostate cancer cells through the regulation of components of the cell-cycle machinery. Oncogene 2010; 29: 345-55.10.1038/onc.2009.32919838216Search in Google Scholar

14. Tassidis H, Culig Z, Wingren AG, Härkönen P. Role of the protein tyrosine phosphatase SHP-1 in Interleukin-6 regulation of prostate cancer cells. Prostate 2010; 70: 1491-500.10.1002/pros.2118420687222Search in Google Scholar

15. Rodríguez-Ubreva FJ, Cariaga-Martinez AE, Cortés MA, Romero-De Pablos M, Ropero S, López-Ruiz P, et al. Knockdown of protein tyrosine phosphatase SHP-1 inhibits G1/S progression in prostate cancer cells through the regulation of components of the cell-cycle machinery. Oncogene 2010; 29: 345-55.10.1038/onc.2009.329Search in Google Scholar

16. Zhang Y, Hagedorn CH, Wang L. Role of nuclear receptor SHP in metabolism and cancer. Biochim Biophys Acta 2011; 1812: 893-908.10.1016/j.bbadis.2010.10.006304316620970497Search in Google Scholar

17. Yang S, Chen J, Guo Y, Lin H, Zhang Z, Feng G, et al. Identification of prognostic biomarkers for response to radiotherapy by DNA microarray in nasopharyngeal carcinoma patients. Int J Oncol 2012; 40: 1590-600.Search in Google Scholar

18. López-Ruiz P, Rodriguez-Ubreva J, Cariaga AE, Cortes MA, Colás B. SHP-1 in cell-cycle regulation. Anticancer Agents Med Chem 2011; 11: 89-98.10.2174/187152011794941154Search in Google Scholar

19. Pawlik TM, Keyomarsi K. Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys 2004; 59: 928-42.10.1016/j.ijrobp.2004.03.00515234026Search in Google Scholar

20. Macaluso M, Montanari M, Cinti C, Giordano A. Modulation of cell cycle components by epigenetic and genetic events. Semin Oncol 2005; 32: 452-7.10.1053/j.seminoncol.2005.07.00916210085Search in Google Scholar

21. Shimura T. Acquired radioresistance of cancer and the AKT/GSK3β/cyclin D1 overexpression cycle. J Radiat Res 2011; 52: 539-44.10.1269/jrr.1109821881296Search in Google Scholar

22. Lopez-Ruiz P, Rodriguez-Ubreva J, Cariaga AE, Cortes MA, Colas B. SHP-1 in cell-cycle regulation. Anticancer Agents Med Chem 2011; 11: 89-98.10.2174/18715201179494115421291405Search in Google Scholar

23. Vinayanuwattikun C, Sriuranpong V, Tanasanvimon S, Chantranuwat P, Mutirangura A. Epithelial-specific methylation marker: a potential plasma biomarker in advanced non-small cell lung cancer. J Thorac Oncol 2011; 6: 1818-25.10.1097/JTO.0b013e318226b46f21964525Search in Google Scholar

24. Insabato L, Amelio I, Quarto M, Zannetti A, Tolino F, et al. Elevated expression of the tyrosine phosphatase SHP-1 defines a subset of high-grade breast tumors. Oncology 2009; 77: 378-84.10.1159/00027676520090381Search in Google Scholar

25. Baker SJ, Reddy EP. Targeted inhibition of kinases in cancer therapy. Mt Sinai J Med 2010; 77: 573-86.10.1002/msj.20220305877821105121Search in Google Scholar

26. Zhang Y, Hagedorn CH, Wang L. Role of nuclear receptor SHP in metabolism and cancer. Biochim Biophys Acta 2011; 1812: 893-908. 10.1016/j.bbadis.2010.10.006304316620970497Search in Google Scholar